Division of Biotechnology, Animal Technology Institute, Taiwan, Chunan, Miaoli, Taiwan.
Stem Cells Dev. 2012 Feb 10;21(3):373-83. doi: 10.1089/scd.2011.0021. Epub 2011 Jun 10.
The inhibition of endogenous differentiation-inducing signaling or the enhancement of growth capacity and viability of preimplantation embryos, via 2i (PD0325901 and CHIR99021), dramatically improves the establishment of mouse embryonic stem cells (mESCs). Using adrenocorticotropic hormone fragments 1-24 (ACTH 1-24), which enhances survival and/or proliferation of mESCs, also increases the derivation of mESCs from single blastomeres significantly. The CHIR99021 pathway and the proposed ACTH pathway are likely different. Therefore, this study aimed to assess the synergetic effects of 2i and ACTH 1-24 on derivation of mESCs. Results in the present study demonstrate that germline-transmitted mESCs could be efficiently derived from ICR and C57BL/6J at 0.5-4.5 days postcoitum denuded zygotes to blastocysts or isolated blastomeres of 2-8-cell embryos and cultured in 10 μL droplets with human foreskin fibroblast (Hs68) or STO (a mouse embryonic fibroblast line) feeders and in knockout serum replacement (KSR) ESC medium containing 2i or ACTH 1-24. The overall success rates for C57BL/6J and ICR were 56.2% when cultured in 2i+ACTH 1-24, 26.6% in 2i, 6.7% in ACTH 1-24, and 4.8% in KSR ESC medium. These results imply that CHIR99021 and ACTH 1-24 are synergistically enhancing the establishment of mESCs. The proposed protocol also demonstrates a highly efficient and reproducible method, has a simple layout, is easy to apply, and could be used as an alternative method for routinely establishing mESC lines.
2i(PD0325901 和 CHIR99021)抑制内源性诱导分化信号或增强着床前胚胎的生长能力和活力,可显著提高小鼠胚胎干细胞(mESC)的建立。使用促肾上腺皮质激素片段 1-24(ACTH 1-24),它增强 mESC 的存活和/或增殖,也显著增加了从单个卵裂球中衍生出 mESC 的数量。CHIR99021 途径和拟议的 ACTH 途径可能不同。因此,本研究旨在评估 2i 和 ACTH 1-24 对 mESC 衍生的协同作用。本研究的结果表明,从 ICR 和 C57BL/6J 的生精系传代 mESC 可以从受精卵 0.5-4.5 天去卵丘裸卵或 2-8 细胞胚胎的分离卵裂球高效地衍生到囊胚或培养在 10μL 液滴中,并用人包皮成纤维细胞(Hs68)或 STO(一种小鼠胚胎成纤维细胞系)饲养细胞以及含有 2i 或 ACTH 1-24 的 KO 血清替代物(KSR)ESC 培养基中。在 2i+ACTH 1-24 中培养时,C57BL/6J 和 ICR 的总体成功率为 56.2%,在 2i 中为 26.6%,在 ACTH 1-24 中为 6.7%,在 KSR ESC 培养基中为 4.8%。这些结果表明 CHIR99021 和 ACTH 1-24 协同增强了 mESC 的建立。所提出的方案还展示了一种高效且可重复的方法,具有简单的布局,易于应用,可以作为常规建立 mESC 系的替代方法。